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This review was written in an attempt to present the reader with a decent spectrum of the available methods for 
gene function analysis that have been applied in the past decade. Knowledge emanating from the functional 
analysis of genes has applications in the fields of genetics and genomics, medical diagnostics, the pharmaceutical 
industry and in plant and animal biotechnology. DNA sequencing provides the primary data for the functional 
analysis of genes by determining the sequence order of nucleic acid residues of a DNA molecule. Computational 
tools are then used for characterization of genes, prediction of function, establishing structural and 
physiochemical properties of proteins, phylogenetic analyses, and performing simulations of the cellular 
interactions of biomolecules. Gene expression is done to analyse promoter activity, detect RNA transcript levels, 
monitor protein expression and post-translational modification. The most common purpose of a gene expression 
study is to find statistically differentially expressed genes. One way to understand the function of a gene is to 
observe a biological system that lacks that gene. Several techniques have been developed to alter a gene 
sequence to result in an inactivated gene. The emergence of genome-editing technologies has provided new tools 
for introducing sequence-specific modifications into genomes. 
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1. INTRODUCTION 
Genes are made up of DNA. Genes are the basic physical and functional unit of heredity. In cells, a gene is a 
portion of DNA that contains both coding sequences that determine what the gene does, and non-coding 
sequences that determine when the gene is active (Griffiths et al. 2015). Their function is to hold all the 
information required to make and regulate the expression of all the different proteins in cells. Genes act as 
instructions to the production of the proteins in the organisms' cell and control what protein is made within the 
cell, which can affect the organism's phenotype or outward appearance (Griffiths et al. 2015). In humans, genes 
vary in size from a few hundred DNA bases to more than 2 million bases. There are both the RNA genes and 
protein-coding genes in the human genome (International Human Genome Sequencing Consortium, 2001).  The 
functions of more than 50% of the discovered genes are unknown, which means that scientists must continue to 
work to find out what these genes do. 
Knowledge emanating from the functional analysis of genes has applications in the fields of genetics 
and genomics, medical diagnostics, the pharmaceutical industry and in plant and animal biotechnology (Sitnicka 
et al. 2010). Functional genomics can be initiated once large-scale sequence data is made available (Griffiths et 
al. 2015). Understanding the function of a particular gene is a multistep process. The primary activity in 
functional genomics is the identification of coding sequences within a genome. This is supported by 
bioinformatics tools, which are used to predict genes. This is then followed with the analysis of gene products to 
measure gene and protein expression patterns that are in turn liked to phenotypes, which offer visual or 
quantifiable observations leading to the recognition of the functions fulfilled by the genes (Sitnicka et al. 2010).  
The final step in functional analysis involves system perturbation where the gene in question is inactivated.  
Over the past few decades, several methods for the analysis of gene function have been developed. 
These developments have been accelerated by advancements in automation, computerization and molecular 
biology and biotechnology techniques (Sitnicka et al. 2010). The aim of this article is to present biotechnological 
developments made so far in the methods for the functional analysis of genes. The function of genes can 
therefore either be predicted by use of computational methods or demonstrated experimentally using wet 
laboratory procedures. 
 
2. DNA SEQUENCING TECHNOLOGIES AND THEIR APPLICATION IN THE ANALYSIS OF 
GENE FUNCTION 
DNA is the information store that ultimately dictates the structure of every gene product. DNA sequencing 
provides the primary data for the functional analysis of genes. Determining the sequence order of nucleic acid 
residues of a DNA molecule is the most comprehensive way of obtaining genetic information about any living 
organism (Berglund et al. 2011; Heather & Chain 2016). Coupled with bioinformatics applications it is possible 
to analyse the nucleic acid sequence data to infer or predict the function of genes. The term DNA sequencing 
refers to applications used to determine the order of the nucleotide bases adenine, guanine, cytosine and thymine 
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in a molecule of DNA. There are two major types of sequencing applications, de novo sequencing and 
resequencing. In de novo sequencing, the genome of an organism is sequenced for the first time. In contrast, in 
resequencing, a reference sequence is already available in the database (Berglund et al. 2011). Advances in 
sequencing technologies have enabled population genetics based on the complete genomic sequences of a large 
number of individuals (Berglund et al. 2011). 
Sanger sequencing, which is based on DNA chain termination with a small concentration of radio- or 
fluorescently-labeled di-deoxy nucleotide triphosphate (dNTPs) molecules followed by size separation by gel 
electrophoresis, is the gold standard for sequencing technology in that it provides a high degree of accuracy, 
long-read capabilities, and the flexibility to support a diverse range of applications in many research areas 
(Dewey et al. 2012). Sanger sequencing is suited for sequencing short segments of DNA and confirming of Next 
Generation Sequencing (NGS) output (Dewey et al. 2012). Sanger Sequencers generate long reads, which enable 
the identification of protein-coding regions in infectious disease and are applicable for metagenomic analyses 
(Rothberg & Leamon 2008). 
The scientific community demanded an increase the throughput of DNA sequencing. Therefore, newer 
technologies that allow rapid sequencing of large amounts of DNA and have the capability to generate high-
throughput data have to be continuously developed. From 2005, a “second-generation” of sequencing 
technologies (referred to as Next generation sequencing (NGS) technologies) became available. These have 
provided unprecedented opportunities for high-throughput functional genomic research. The technologies 
include the 454 Sequencer (Roche), Illumina Genome Analyzer and SOLiD system (Applied Biosystems). These 
technologies are applied in whole-genome sequencing, targeted resequencing, discovery of transcription factor 
binding sites, and noncoding RNA expression profiling (Morozova & Marra 2008). The advantage of the NGS 
technologies is that they are able to generate higher volumes of sequence data with a fast turnaround time at a 
much lower cost that is achieved by Sanger sequencing (Berglund et al. 2011). This in turn has revolutionized 
genomics and has led to a significant increase in the number of genome sequencing projects. NGS is best for 
examining hundreds of genes at a time or sequencing samples with a low amount of starting material.  
Of the NGS platforms that are currently commercially available, the 454 sequencer was the first to 
reach the market (Rothberg & Leamon 2008). It utilises pyrosequencing, which is based on the detection of light 
emitted by secondary reactions initiated by the release of pyrophosphate whenever a nucleotide is incorporated 
(Rothberg & Leamon 2008).  The advantages of the 454 sequencer include long reads and short run time. The 
major disadvantage is that it has the highest cost per base of any of the NGS systems. (Rothberg & Leamon 
2008). The second technology brought to market after the 454 was the Genome Analyzer conceived by Solexa 
(Cambridge, UK) and commercialized by Illumina (Hayward, CA, USA) (Rothberg & Leamon 2008). The 
Solexa system operates via a sequencing-by-synthesis process that incorporates base-specific fluorescently 
labelled “end-blocked nucleotides,” which do not allow further DNA polymerization into immobilized template 
strands. The Illumina platform has a higher yield of data than the 454 sequencer. The Illumina platform is widely 
used for a variety of applications, including human whole genome and exome variant discovery and 
transcriptome sequencing (RNAseq) (Berglund et al. 2011). The SOLiD (Applied Biosystems by Life 
Technologies) sequencing process differs from the 454 and Illumina methods in that it relies upon sequencing by 
ligation in which the sequence of a DNA template is read by competitive ligation of 2-base probes to the nascent 
DNA strand (Rothberg & Leamon 2008). Advantages include high throughput and Inherent error correction, 
both of which make the platform suitable for human whole genome and exome variant discovery (Berglund et al. 
2011). The short read-lengths of both Illumina and SOLiD, coupled with the decreased sequencing costs 
afforded by the high-read densities make these two technologies ideal for applications such as sequence-based 
expression analysis and promoter binding site studies (Rothberg & Leamon 2008). 
Unlike NGS platforms, which produces short reads a few hundred base-pairs long, “third” generation 
technologies have been used to produce highly accurate de novo assemblies with unprecedented lengths of 
sequence reads with over 10,000 bp reads or map over 100,000 bp molecules (Bleidorn  2016; Zhou et al. 2016). 
Increased read lengths can be used to address long-standing problems in de novo genome assembly. Third 
generation sequencing instruments negate the requirement for DNA amplification.  By foregoing this step, these 
technologies avoid PCR-introduced error and amplification bias, and may be superior for high-throughput 
sequencing applications, such as transcriptome sequencing (“RNAseq”), that depend on accurate quantification 
of relative DNA or RNA fragment abundance. (Heather & Chain 2016).  The first of these single-molecule 
sequencing technologies is the Helicos Heliscope (Helicos BioSciences). The Helicos chemistry worked in the 
same manner that Illumina does, but without any bridge amplification (Heather & Chain 2016).  It produced 
relatively short reads. The Pacific Biosciences offers a platform (referred to as ‘‘PacBio sequencing”) for single-
molecule, real-time sequencing with longer read lengths (Rhoads & Au 2015). The highly contiguous de novo 
assemblies can close gaps in reference assemblies and characterize structural variation in individual genomes. 
With longer reads, it becomes possible to sequence through extended repetitive regions and detect mutations 
(Rhoads & Au 2015). PacBio sequencing provides information for the detection of base modifications, such as 
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methylation. Nanopore DNA strand sequencing has emerged as a competitive, portable technology. Nanopore 
sequencing detects base-specific changes in ionic flux as DNA traverses small pores in solid surfaces that are 
placed in an electric field. As the DNA passes through the pore, a sensor detects ionic current changes caused by 
differences in the shifting nucleotide sequences (Deamer et al. 2016; Bayley 2015). Reads exceeding 150 kb 
have been achieved. The Oxford Nanopore MinION (a portable sequencing device the size of a cell phone) is the 
dominant platform currently available (Jain et al. 2016). Nanopore technology can detect modifications on 
individual nucleotides. The technology can achieve read lengths of more than 50 kb with high read accuracies 
(Jain et al. 2016). 
 
3. PREDICTION OF GENE FUNCTION USING COMPUTATIONAL METHODS 
3.1 Genomic resources and bioinformatics tools for gene function analysis 
Experimental approaches for the analysis of gene function cannot scale up to accommodate the vast amount of 
sequence data available due to its inherent difficulty (which is expensive, time consuming and tedious) 
(Radivojac et al. 2013). Previously, in the absence of direct experimental demonstration, homology-based 
protein function prediction was used as the gold standard for in silico analysis and prediction of protein function 
(Grant 2011). Computational tools are therefore routinely used for characterization of genes, prediction of 
function, establishing structural and physiochemical properties of proteins, phylogenetic analyses, and 
performing simulations of the cellular interactions of biomolecules (Mehmood et al. 2014). Although these tools 
cannot generate information as reliable as experimentation, they can still facilitate informed decision for 
conducting costly experimentation (Mehmood et al. 2014). For computational predictions to be reliable, it is 
crucial that their accuracy be high (Radivojac et al. 2013).  Among the methods available are methods tools for 
primary sequence analyses (such as gene identification and sequence analyses from primary databases), 
Predicting Protein Structure and Function using Protein Sequence Databases (Mehmood et al. 2014). More tools 
for analysing genomes, proteomes, predicting structures, rational drug designing and molecular simulations are 
still being developed. As sequencing technologies advance, biologists are slowly drowning in their data and new 
tools are required to perform the “downstream” analyses. The availability of high-throughput experimental data 
of genomic sequences from thousands of species has created new opportunities for function prediction 
(Radivojac et al. 2013).   
 
3.2 Predicting gene function through homology 
Similarity-based studies are the most widely used approach for function prediction (Grant 2011). The communal 
availability of multiple complete genomes sequences of diverse life forms, which are stored in databases for 
comparative analysis, provides a new perspective to genome analysis and allows for comparison with 
homologous sequences for relationships between genes (Koonin 2005). An analysis showing similarity with the 
recognised genes is helpful in the initial determination of a probable gene product and its function (Sitnicka et al. 
2010). This method of predicting through homology relies on the assumption that if a newly sequenced gene is 
highly sequence-similar to an already characterized and published gene, the function of the new gene is probably 
similar to the experimentally verified function of the annotated homolog and that is used as the basis to infer the 
function of the sequence under investigation (Grant 2011; Sitnicka et al. 2010).  
Homologs are genes sharing a common origin. There are subcategories of homologs: Orthologs are 
genes related via speciation (vertical descent). They originate from a single ancestral gene in their common 
ancestor. Orthologs occur in various species (which may also prove that they have occurred in a common 
ancestor) and fulfil the same or comparable functions (Koonin 2005). Xenologs are homologous genes, which 
are acquired by organisms through horizontal gene transfer (Poptsova & Gogarten 2007). Paralogs are genes 
related via duplication. They occur in various organisms or may occur in the same individual, but due to changes 
in structure, they have separate roles (Koonin 2005). In this case the duplication leads to divergence, that is, a 
division of functions. Human myoglobin and hemoglobin are examples of two paralogs responsible for the 
storage of oxygen in skeletal muscles and transport of oxygen between cells and pulmonary alveoli respectively 
(Sitnicka et al. 2010). 
The most commonly used database with full sequences of genomes is the National Center for 
Biotechnology Information (NCBI) server (Ghosh & Febin 2016). The use of the BLAST algorithm on the NCBI 
server for homology studies is limited when the similarity between the studied sequences is low (20-30%) 
(Gowri & Sandhya 2006). Proteins may differ significantly at the amino acid level but can however, assume a 
similar structure and fulfil similar functions. Studies on evolution show that the structure of proteins is better 
preserved than their sequence (Ginalski et al. 2003). Due to this, studies on protein structure are important when 
determining their functions (Sitnicka et al. 2010). 
The greatest limitation in homology-based methods is presence of uncharacterized sequences in 
databases (Sitnicka et al. 2010). Several non-homology based approaches for protein function prediction that are 
based on sequence features, structure, evolution, biochemical and genetic knowledge have emerged (Grant 
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3.3 Characterization of the proteome by open reading frame (ORF) analysis 
Double stranded DNA encodes six different reading frames due to its triplet code. Three frames on one DNA 
strand in 5′ to 3′ direction and further three frames on the antisense strand. Gene-prediction software analyse 
genomic DNA sequences by examining each of the six reading frames and searches for Protein-coding segments 
encoded in Open Reading Frames (ORFs) delimited by the translational start codon AUG and ending with a stop 
codon (Grifiths et al. 2015; Mir et al. 2012). Candidates for genes are identified by ORFs of at least 100 codons. 
Most ORFs are completely novel, not corresponding to any familiar gene with alleles producing identifiable 
phenotypes. The ORFs can be analysed for function initially by using the computer to search databases to look 
for full or partial homology to known genes characterized in other organisms. A provisional proteome gene 
distribution can be deduced from such analysis (Grifiths et al. 2015). The genome length influences the number 
of ORFs it carries and the probability to observe very long ORFs. A larger genome will harbour more ORFs (Mir 
et al. 2012). 
 
3.4 Computational Approaches for Functional Prediction and Characterisation of Noncoding RNAs 
Only a small fraction of the genomes of large multicellular eukaryotes code for proteins. The rest is mostly 
comprised of non-protein coding DNA. The same can be said of the majority of the human transcriptome, which 
is defined as non-coding RNA (ncRNA) (Veneziano et al. 2015). The discovery of transfer RNA and ribosomal 
RNA in the 1950s highlighted the presence of non-coding RNAs (ncRNAs) with biological roles. A non-coding 
RNA (ncRNA) is a functional RNA molecule that is transcribed from DNA but not translated into proteins 
(Palazzo & Lee 2015). The best candidates for novel functional ncRNAs arise from only a minute fraction of the 
genome. A vast majority of ncRNAs has yet to be characterized thoroughly (Palazzo & Lee 2015; Signal et al. 
2016). ncRNAs can have numerous molecular functions, including modulating transcriptional patterns, 
regulating protein activities, serving structural or organizational roles, altering RNA processing events, and 
serving as precursors to small RNAs (Wilusz et al. 2009). Those ncRNAs that appear to be involved in 
epigenetic processes can be divided into two main groups; the short ncRNAs (<30 nts) and the long ncRNAs 
(>200 nts).  The three major classes of short non-coding RNAs are microRNAs (miRNAs), short interfering 
RNAs (siRNAs), and piwi-interacting RNAs (piRNAs). Whole genome annotation studies have revealed that a 
much larger fraction of large genomes is transcribed than initially known (Mackowiak et al. 2015). Current 
computational approaches for ncRNA analysis are based on deep sequencing using next-generation sequencing 
(NGS) Output. A ncRNA bioinformatics analysis system has three essential components: a data analysis 
platform for ncRNA detection, classification and expression analysis representing the core of the system; a 
database for annotation information storage and for the analysis of results (Veneziano et al. 2015). 
 
4. EXPERIMENTAL TECHNIQUES AND APPLICATIONS FOR ANALYSIS OF GENE FUNCTION 
A gene is a locus (or region) of DNA, which is the molecular unit of heredity. Even though nearly every cell in 
an organism's body contains the same set of genes, only a fraction of these genes are used in any given cell at 
any given time. Cells in all living organisms are continually activating or deactivating genes (Griffiths et al. 
2015). Every gene consists of functional components, each involved in a different facet of the process of gene 
expression. The two main functional components of a gene are: the promoter region and the coding region. The 
promoter region (with or without cis-acting elements called enhancers) controls when and in what tissue a gene 
is expressed. The coding region is the component of a gene that determines the amino acid sequence of the 
protein encoded by the gene (Griffiths et al. 2015). The main function of genes, therefore, is to control the 
synthesis of proteins in an organisms' cell. When a particular protein is required by the cell, the gene coding for 
that protein is activated. Genes specify the structure of proteins, which in turn are responsible for the associated 
phenotypic structure and function of each cell in the body. Genes are thus responsible for all inherited traits 
(Berg et al. 2015). 
Genes encode proteins and proteins direct cell function. According to the central dogma of molecular 
biology, information flows from DNA to RNA and finally to proteins (Berg et al. 2015). Gene expression is the 
process by which genes are transcribed and translated to yield functional gene products — functional RNA 
species or protein products. Gene expression is a highly regulated mechanism that controls the function and 
adaptability of all living cells. Each step in the flow of information provides the cell with a potential control 
point for self-regulating its functions by adjusting the amount and type of proteins it synthesizes (Griffiths et al. 
2015). At any given time, the amount of a particular protein in a cell reflects the balance between that protein's 
anabolism and catabolism biochemical pathways (Berg et al. 2015). Gene expression is dynamic, and the same 
gene may act in different ways under different circumstances. The most common purpose of a gene expression 
study is to find statistically differentially expressed genes (Sweeney et al. 2017), which are determined by 
comparing sample-level gene expression data between cases and controls. The study of gene function in the 
developmental process is determined by comparing the expression patterns between species. A particular 
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emphasis is put on genes, which exhibit either rapid changes in expression, which have been linked to numerous 
interesting developmental differences, or deep conservation of expression patterns, which have been show to 
underlie developmental similarities on unexpectedly large evolutionary scales (Roux et al. 2015). The study of 
gene regulation provides insights into normal cellular processes, such as differentiation, and abnormal or 
pathological processes.  
The field of gene expression analysis has undergone major advances. Several techniques now exist for 
studying and quantifying gene expression and its regulation: the analysis of promoter activity, detection of RNA 
transcript levels, monitoring protein expression and post-translational modification and gene inactivation 
methods. 
 
4.1 The analysis of promoter activity 
A promoter is linked to the coding region of a gene and regulates the gene’s transcription, either by activating or 
suppressing its expression (Griffiths et al. 2015). In silico screening is used to predict promoter regions of genes. 
However, the analysis of promoter activity is achieved by the expression of promoter/reporter genes fusions in 
host cells. Instead of directly measuring the level of target gene mRNA, the promoter region of the gene of 
interest can be cloned in front of a detectable reporter gene such as luciferase, β-galactosidase or β-glucuronidase 
and measure the reporter gene expression as a reflection of the expression of the gene of interest (Fu & Xiao 
2006). A reporter gene is a gene whose phenotype can easily be detected or measured quantitatively (Griffiths et 
al. 2015). Promoter activity is thus measured as the rate of transcription of the downstream reporter gene. 
Promoter/reporter constructs are tested in cell lines that most closely approximate the tissue that you are 
interested in. Gene expression is in part regulated by transcription factors that bind specific sequence motifs in 
genomic DNA to either upregulate or downregulate transcription. Gel shift assays are used to study protein-DNA 
or protein-RNA interactions. This is an electrophoretic mobility shift assay; a powerful technique to resolve 
nucleic acid-protein complexes formed with transcription factors in nuclear extracts (Parés-Matos 2013). DNA 
or RNA fragments that are tightly associated with proteins (such as transcription factors) migrate more slowly in 
an agarose or polyacrylamide gel (showing a positional shift). Identifying the associated sequences provides 
insight into gene regulation (Parés-Matos 2013). 
 
4.2 Detection of RNA transcript levels   
mRNA is the intermediary between DNA and protein in the course of gene expression (Berg et al. 2015). By 
determining which mRNA transcripts are present in a cell, it is possible to determine which genes are expressed 
in that cell at different stages of development and under different environmental conditions. The amount of 
mRNA produced correlates with the amount of protein eventually synthesized and measuring the amount of a 
particular mRNA produced by a given cell or tissue is often easier than measuring the amount of the final 
protein. Molecular characterization of any gene usually includes the analysis of temporal and spatial distribution 
of RNA expression. A number of widely used procedures exist for detecting and determining the abundance of a 
particular mRNA in a total or poly(A) RNA sample. Subsequently, this information can be used to help 
determine what circumstances trigger expression of various genes. 
The study of the expression patterns of a few genes at a time is done on a small scale by applying 
techniques such as quantitative RT-PCR or in situ hybridization (Roux et al. 2015). Northern blot or serial 
analysis of gene expression (SAGE) make it possible to identify which genes are turned on and which are turned 
off within cells. Northern blotting is a technique where levels of mRNA are directly quantified by 
electrophoresis and immobilized on a membrane followed by incubation with specific probes. The RNA-probe 
complexes can be detected using a variety of different chemistries or radionuclide labelling.  
mRNA levels can be quantified by reverse transcription of the RNA to cDNA followed by quantitative 
PCR (qPCR) on the cDNA. Expression levels can be measured relative to other genes (relative quantification) or 
against a standard (absolute quantification). Real-time PCR is the gold standard in nucleic acid quantification 
because of its accuracy and sensitivity. Real-time PCR can be used to quantify mRNA or miRNA expression 
following conversion to cDNA or to quantitate genomic DNA directly to investigate transcriptional activity. 
Transcriptomics is the study of the complete set of RNA transcripts (transcriptome) that are encoded by 
the genome of a specific cell or organism, at a specific time or under a specific set of conditions or specific 
circumstances, using high-throughput methods, such as microarray analysis (Jenkinson et al. 2016). Comparison 
of transcriptomes allows the identification of genes that are differentially expressed in distinct cell populations, 
or in response to different environmental stimuli (Evans 2015). The study of RNA expression patterns on a 
genome-wide scale can be achieved using Microarrays and RNA sequencing (RNA-seq) (Roux et al. 2015), 
which is helping researchers discover novel RNA forms and variants. New technologies promise to reveal even 
more about RNA and make RNA-based assays common. The volume of transcriptomics data, whether from 
microarrays or RNA-seq experiments, is increasing exponentially in public databases (Roux et al. 2015). All 
microarray and RNA-seq datasets come from public repositories. While RNA-seq and microarrays provide 
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genome-wide information, they often lack the fine resolution of in situ hybridizations, which are mostly small-
scale (Roux et al. 2015). 
DNA microarrays also known as biochip or DNA chip is an array of oligonucleotide probes bound to a 
chip surface to enable simultaneous gene expression profiling of many genes. Labelled cDNA from a sample is 
hybridized to complementary probe sequences on the chip, and strongly associated complexes are identified 
optically (Griffiths et al. 2015). The microarrays are used to determine expression levels across a large number 
of genes or to perform genotyping across different regions of a genome. High throughput transcriptomics 
became possible with microarrays, which detect nucleic acids in a sample by hybridization to probes on 
microchips. Microarrays allowed the first large-scale comparative studies of the evolution of gene expression 
between species (Roux et al. 2015). Microarrays are particularly useful for analysing large mammalian 
transcriptomes. DNA chips can also be used to detect mutations (Griffiths et al. 2015). However, microarrays 
detect only known sequences, so they can’t be used for discovery.  
Transcriptomics has expanded dramatically in the past few years because of developments in RNA 
sequencing (RNA-seq) (Conesa et al. 2016). Use of RNA-seq has exploded because of next generation 
sequencing (NGS), which can yield readouts of billions of bases a day from a single instrument. RNA-seq can 
qualitatively and quantitatively investigate any RNA type including messenger RNAs (mRNAs), microRNAs, 
small interfering RNAs, and long noncoding RNAs. RNA-seq analysis of RNA isoforms, which are transcribed 
from the same gene but have different structures, for example because of alternative splicing, are explaining how 
limited genomes produce complex phenotypes (Conesa et al. 2016). RNA-seq aids scientists working on unusual 
model organisms, who use the method to assemble de novo transcriptomes for organisms without sequenced 
genomes. Most researchers, however, are interested in differential gene expression, changes in the levels of 
protein-coding mRNAs in experimental samples versus controls. RNA-seq is now allowing major progresses in 
describing gene expression variation between species. This technique has a larger dynamic range than 
microarrays, and can also be used to study differences in exon usage and alternative splicing (Gallego et al. 
2012). Importantly, it allows the study of non-model species in the absence of a sequenced genome (Grabherr et 
al. 2011; Perry et al. 2012), or when the genome sequence is of poor quality. The advantages of RNA-seq allow 
more straightforward direct comparisons of expression levels between species, and interesting insights have been 
provided by the first evolutionary studies using this technology (Roux et al. 2015). Comparative RNA-seq can 
be used in functional genomics (Roux et al. 2015). 
 
4.3 Proteomic analysis  
Proteomic analysis (proteomics) refers to the systematic identification and quantification of the proteome (the 
complete complement of proteins) of a biological system (cell, tissue, organ, biological fluid, or organism) at a 
specific point in time (Ortea et al. 2016). Studying proteins generates insight on how proteins affect cell 
processes. The biggest challenge inherent in proteomics lies in the proteome's degree of complexity compared to 
the genome. For example, one gene can encode more than one protein (International Human Genome 
Sequencing Consortium, 2001), the proteome is dynamic and is constantly changing according to different 
stimuli (Larance & Lamond 2015; Ortea et al. 2016), proteins are post-translationally modified and exist in a 
wide range of concentrations in the body. 
Proteins can be organized in four structural levels: primary (The amino acid sequence), secondary 
(Local folding of the amino acid sequence into α helices and β sheets), tertiary (3D conformation of the entire 
amino acid sequence) and quaternary (Interaction between multiple small peptides or protein subunits to create a 
large unit) (Berg et al. 2015). Each level of protein structure is essential to the finished molecule's function. The 
primary sequence of the amino acid chain determines where secondary structures will form, as well as the 
overall shape of the final 3D conformation. The 3D conformation of each small peptide or subunit determines 
the final structure and function of a protein conglomerate (Griffiths et al. 2015). 
There are different subdivisions of proteomics, including: structural proteomics (analysis of protein 
structure) (Manjasetty et al. 2012), expression proteomics (analysis differential expression of proteins) 
(Chernobrovkin et al. 2015) and interaction proteomics (characterization of protein complexes) (Völkel et al. 
2010). Several tools are available for conducting proteomics analysis.  
Mass spectrometry is the technique most often used for proteomic analysis (Aebersold 2003; Maarten et 
al. 2013). It allows scientists to detect and quantify proteins in a complex biological matrix. Mass spectrometry 
(MS) measures the mass-to-charge ratio of ions to identify and quantify molecules in simple and complex 
mixtures (Aebersold 2003). The development of high-throughput and quantitative MS proteomics workflows 
within the last two decades has expanded the scope of what we know about protein structure, function, 
modification and global protein dynamics (Larance & Lamond 2015). In proteomics research, mass spectrometry 
is used to determine protein structure, function, folding and interactions, identify a protein from the mass of its 
peptide fragments, detect specific post-translational modifications throughout complex biological mixtures, 
quantitate (relative or absolute) proteins in a given sample and to monitor enzyme reactions, chemical 
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modifications and protein digestion (Schmidt et al. 2014). 
Western blotting is used to quantify the relative expression levels for specific proteins by 
electrophoretically separating extracted cell proteins, transferring them to a membrane, and then probing the 
bound proteins with antibodies (targeted to antigens of interest) that are subsequently detected using various 
chemistries or radiolabelling (Griffiths et al. 2015). By using a western blot, researchers are able to identify 
specific proteins from a complex mixture of proteins extracted from cells. The Western blotting technique uses 
three elements to accomplish this task: SDS-PAGE separation of the proteins by size, transfer of the separated 
proteins from the gel to a solid support, and visualizing the target protein using a proper primary and secondary 
antibody (Mahmood & Yang 2012). 
Two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) is a technique for separating a 
complex mixture of proteins in two dimensions and then staining to detect differences at the whole-proteome 
level (Ortea et al. 2016). It is capable of resolving thousands of proteins in a single run. In the first dimension, 
proteins are separated based on differences in isoelectric point (pI). In the second dimension, they are separated 
according to molecular weight. Following separation, 2-D electrophoresis gels are stained for protein 
visualization and analysis (Mayer et al. 2015). In combination with computer-assisted image evaluation systems 
for comprehensive qualitative and quantitative examination of proteomes, this electrophoresis technique allows 
cataloguing of proteins and comparison of data among groups of researchers. 2-D PAGE is well suited for the 
analysis of posttranslational protein modifications. It is particularly useful for low-abundance proteins (Mayer et 
al. 2015). 
Immunoassays are techniques that exploit the sensitivity and specificity of antibody-antigen interactions 
for detection of target analytes in biological samples.   Immunoassays are important for protein detection and 
quantification (Tak For Yu et al. 2015). Proteins are quantitated in solution using antibodies that are bound to 
color-coded beads or immobilized to a surface, which is subsequently probed with an antibody suspension and is 
typically detected using a chromogenic or fluorogenic reporter. Immunoassays can be used to determine levels of 
protein phosphorylation and other post-translational modifications by detecting these attachments using 
antibodies that are specific for them (Chen et al. 2015). 
Proteomics has both a physical laboratory component and a computational component. Bioinformatics 
in protein analysis is applied for database searches, sequence comparisons and structural predictions (Oliva et al. 
2012), analysis of protein post-translational modifications, protein-protein interactions (Abellan 2013) and 
computational methods for mass spectrometry-based proteomics (Li & Tang 2016). 
 
4.4 Gene inactivation methods  
One way to understand the function of a gene is to observe a biological system that lacks that gene. The ability to 
manipulate the expression levels of specific genes into their respective final protein products has been essential 
for understanding the functions of specific genes in the study of biological processes (Guo et al. 2014; Yu & 
Yuan 2010). Scientists are now able to modulate the expression of genes of interest and precisely modify the 
genomic sequences in virtually any organisms (Guo et al. 2014). Several techniques have been developed to alter 
a gene sequence to result in an inactivated gene, or one in which the expression is inactivated at a chosen time 
during development to study the loss of function of the gene. It is therefore possible to identify altered gene 
expression that may underpin a particular disease condition. Gene inactivation events can have varying effects 
on phenotypes (Balasubramanian et al. 2011). Traditionally, gene manipulation focused on introducing a foreign 
target gene into host cells and tissues through recombinant DNA technology and gene transfer techniques to 
express the gene of interest (Yu & Yuan 2010). In the past few years, there has been a revolution in the 
approaches scientists use to inactivate gene expression, such as the development of highly efficient gene 
knockdown with ribonucleic acid interference (RNAi) delivery systems and the groundbreaking genome editing 
technologies of zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and 
clustered regularly interspaced short palindromic repeats (CRISPR) (Swamy et al. 2016; Guo et al. 2014).  
4.4.1 Gene knockdown by in vivo RNA regulation  
RNA medicine is the therapeutic targeting of mRNA using synthetic RNA molecules. Two major methods are 
employed: the use of antisense RNAs and RNA-interference (RNAi) mediated by double-stranded RNA (Chery 
2016). 
4.4.1.1 Translation blockage by antisense RNA hybridization to target mRNA 
Antisense RNAs are small, highly structured single-stranded molecules that act through sequence 
complementarity to bind and inhibit targeted specific mRNA (sense RNA) RNA function for example, inhibition 
of translation to protein. Antisense RNA technology works through many mechanisms depending, in part, on the 
region in the RNA sequence that is targeted (Chery 2016). 
Antisense RNA technology was used to synthesize a complementary mRNA to Polygalacturonase (PG) 
gene and inhibits the synthesis of PG enzyme thus delaying over ripening and rotting of tomatoes (García-Gago 
et al. 2009). Antisense RNA technology has applications also in the fields of gene therapy, cancer therapy and 
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therapies of several other disorders (Evers et al. 2015). Research is also on going on the development of 
antisense antiviral drugs and other RNA therapeutics  (Chery 2016). 
Protein production is controlled by ribosome binding to the messenger RNA (mRNA) (Eriksen et al. 
2017). Weaker ribosome binding sites can result in a decrease in protein yield. Antisense RNA molecules can be 
utilized to control gene regulation. Naturally occurring antisense RNAs have been isolated in a various microbes, 
including the E. coli (Thomason et al. 2010). Riboswitches are elements in bacterial commonly found in the 5-
untranslated region (UTR) of mRNAs that exert their regulatory control over the transcript in a cis-fashion by 
directly binding a small molecule ligand to regulate expression of the downstream coding sequence(s) without a 
requirement for regulatory proteins (Garst et al. 2011). The regulatory signal is an effector molecule that binds 
the nascent RNA transcript, causing a change in the RNA structure (Fuchs et al. 2007). The structural 
rearrangements can sequester the ribosome-binding site to regulate at the level of translation initiation. Inhibition 
of translation initiation in bacteria is achieved when ligands sequester the Shine-Dalgarno (SD) sequence of the 
mRNA through alternative base pairing, resulting in occlusion of the ribosomal binding site (Rinaldi et al. 2016). 
RNA molecules can be engineered to be regulatory molecules for base-paring and ligand-induced 
conformational change for gene regulation as riboswitches (Wittmann & Suess 2012). 
4.4.1.2 mRNA degradation by RNA interference (RNAi) 
RNA interference (RNAi) (also known as post-transcriptional gene silencing (PTGS)) is an endogenous 
biological RNA-dependent gene regulatory mechanism by which noncoding double-stranded RNA (dsRNA) 
molecules induce gene silencing by targeting complementary mRNA for degradation (Kelly & Hurlstone 2011; 
Agrawal et al. 2003) thus suppressing the synthesis of protein. In the absence of this protein one can look for 
clues on the function of this protein. RNAi is a conserved biological response to double-stranded RNA. RNA in 
cells naturally exits as a single-stranded nucleic acid molecule (unlike DNA which is double -stranded) (Chery 
2016). 
The RNAi pathway is initiated when dsRNA enters the cytoplasm. Endogenous triggers of RNAi 
pathway include double-stranded RNA (dsRNA) of viral origin, aberrant transcripts from repetitive sequences in 
the genome such as transposons and unique endogenous small RNAs including microRNA (miRNA) 
endogenous small interfering RNAs (endo-siRNAs), and Piwi-interacting RNAs (piRNAs) (Okamura & Lai 
2008; Czech et al. 2008). RNAi is a naturally occurring pathway thought to have evolved in plants and animals 
over millions of years as a form of innate immunity defence against viruses, suggesting an important role in 
pathogen resistance (Meng et al. 2013).  
RNAi can be triggered experimentally by exogenous introduction of dsRNA or using DNA-based 
vectors, which express short hairpin RNA (shRNA) in the cytoplasm that are processed by Dicer into siRNAs 
(Swamy et al. 2016; McGinnis 2010). RNAi can also be induced directly by transfecting cells with siRNAs with 
dinucleotide 3' overhangs (Fitzgerald et al. 2017). 
A simplified model for the RNAi pathway is based on two steps, each involving ribonuclease enzyme. 
In the first step, the trigger RNA (either dsRNA or miRNA primary transcript) is processed into a small 
interfering RNA (siRNA) by the RNase II enzyme, Dicer and RNaseIII endonuclease, Drosha (which cleave the 
long dsRNA into short double-stranded fragments of 20–25 base pairs (bp) small interfering RNAs (siRNAs)) 
(McGinnis 2010; Kelly & Hurlstone 2011; Li & Patel 2016). In the second step, siRNAs are loaded and 
assembled into the effector complex RNA-induced silencing complex (RISC). The siRNA is unwound during 
RISC assembly and the antisense strand of the siRNA duplex becomes part of a multi-protein complex RISC and 
then hybridizes with the mRNA target as it guides the RISC to bind to the target mRNA molecules. The RISC 
cleaves the mRNA, leading to specific gene silencing (Kelly and Hurlstone, 2011; Agrawal et al. 2003) as a 
result of nucleolytic degradation of the targeted mRNA by the RNase H enzyme Argonaute (Slicer) (Pompey et 
al. 2014). Argonautes are the key effectors of RNA interference (RNAi) pathways (Kaya et al. 2016).  If the 
siRNA/mRNA duplex contains mismatches the mRNA is not cleaved (Swamy et al. 2016). 
RNAi is a specific, potent, and highly successful approach for loss-of-function studies in virtually all 
eukaryotic organisms (McGinnis 2010; Pompey et al. 2014; Koch et al. 2016). RNAi technology takes 
advantage of the cell’s natural machinery, facilitated by short interfering RNA molecules, to effectively knock 
down expression of a gene of interest (Swamy et al. 2016). RNAi technology is precise (ability to target and 
silence individual genes, even among a family of closely related genes) (McGinnis 2010), fast (thousands of 
genes can be rapidly targeted using RNAi), stable (traits based on RNAi have been shown to be stable for at least 
five generations) (Brown et al. 2003), flexible (RNAi effective for different species and phenotypes) and 
controllable (genes can be turned off completely or just have their effects ‘turned down’) (McGinnis 2010). The 
high degrees of efficiency and specificity of RNAi make it is one of the most important technological 
breakthroughs in functional genomics by allowing us to directly observe the phenotypes resulting from the 
systematic loss-of-function of genes (McGinnis 2010). With RNAi technology it is possible to efficiently block 
the expression of a specific gene and evaluate its response to changes the environment. RNAi technology can be 
used to assess the functions of thousands of genes within the genome that potentially participate in disease 
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4.4.2 Gene knockout by mutagenesis  
Gene targeting in mouse embryonic stem cells is an established technique for creating animal models for human 
disease or to study gene function at a whole animal level (van Deursen 2002). Gene targeting in mouse 
embryonic stem cells has become the 'gold standard' for determining gene function in mammals. Gene targeting 
is the process of disrupting or mutating a specific genetic locus with the intention of making knockout 
individuals (Gerlai 2016). Gene function can be investigated by systematically looking for any mutant phenotype 
that might provide clues about the function of the gene (Griffiths et al. 2015). 
Gene targeting by homologous recombination enables the exchange of genetic information between 
genomic and exogenous DNA molecules via crossing-over events (Gerlai 2016). These exchanges are guided by 
flanking homologous sequences that direct the cell’s own enzymatic machinery. Homologous recombination 
provides a tool for targeted defined modifications of genes of interest, for the purpose of exploring gene function 
(Reh & Vasquez 2014). Gene targeting with homologous recombination created a revolution in the analysis of 
the function of genes by allowing unprecedented precision with which one could manipulate genes and study the 
effect of this manipulation (Gerlai 2016). The targeting construct is usually a plasmid that contains two long 
stretches of genomic DNA, called homology arms, which are designed to match as closely as possible the 
genomic DNA of the embryonic stem cell line being targeted (Reh & Vasquez 2014). These arms drive the 
homologous recombination event that results in insertion of the construct into the desired locus. This process is 
underway in the fully sequenced genomes.  
Genome editing is a genetic approach used to directly manipulate an organism's genome by inserting, 
replacing, or removing DNA sequences. Permanent change in DNA leads to the loss of function of a gene (Gaj et 
al. 2016). Recently developed techniques using Engineered nucleases, such as zinc-finger nucleases (ZFNs) 
(Urnov et al., 2010), transcription activator-like effector nucleases (TALENs) (Gerlai 2016) and most recently, 
the bacterial clustered regularly interspaced short palindromic repeat (CRISPR)/Cas (CRISPR-associated) 
system have the potential to target genes directly in embryos, without the need to use embryonic stem cells (Guo 
et al. 2014; Gerlai 2016). 
In some cases, knocked-out ORFs show no phenotypic effects due to the compensatory effects of other 
genes in the genome. More than half of the predicted ORFs may fall into this category (Grifiths et al. 2015). 
When this happens, the phenomenon of compensation undermines our ability to answer the question originally 
thought of as the main goal of gene targeting (Gerlai 2016). 
4.4.2.1 Gene knockout by transposon-mediated insertional mutagenesis 
Transposable genetic elements (also referred to as transposons or "jumping genes") are DNA sequences that can 
change their position within a genome, sometimes creating or reversing mutations or altering the cell's genome 
size (Griffiths et al. 2015). Transposons are found in almost all organisms (both prokaryotes and eukaryotes) 
(Griffiths et al. 2015). They occur in large numbers, for example, they make up approximately 50% of the 
human genome (International Human Genome Sequencing Consortium, 2001) and up to 90% of the maize 
genome (SanMiguel et al. 1996). They have an enzyme, transposase (encoded by the transposon itself), which 
they require for excision and insertion (Silva et al. 2011). DNA transposons are flanked at both ends by terminal 
inverted repeats (ITRs) and a single open reading frame that encodes a transposase. The inverted repeats are 
complements of each other (Griffiths et al. 2015). Retrotransposons have long terminal repeats (LTRs) on both 
ends (Finnegan 2012). Transposition occurs using one of the following mechanisms: In cut-and-paste 
transposition, an element is cut out of one site in a chromosome and pasted into a new site. In replicative 
transposition, an element is replicated, and one copy is inserted at a new site; one copy also remains at the 
original site. In retrotransposition, an element’s RNA is used as a template to synthesize DNA molecules, which 
are inserted into new chromosomal sites (DeNicola et al. 2015; Griffiths et al. 2015). Transposons are non-
targeted gene transfer vehicles (Silva et al. 2011). A transposon can either disrupt gene function when it 
integrates into the open reading frame or it can activate expression when inserted upstream of a gene as the 
promoter to drive the expression of downstream sequences (DeNicola et al. 2015). Transposon-mediated 
insertional mutagenesis provides a method for near-random mutation. This approach is particularly useful for 
organisms that are relatively refractory to genetic manipulation (Lin et al. 2014).  
4.4.2.2 Targeted Genome editing using engineered nucleases 
The emergence of genome-editing technologies has provided new tools for introducing sequence-specific 
modifications into genomes. Engineered nucleases enable the manipulation and targeted alteration of any 
genomic sequence in a wide range of cell types and organisms (Gaj et al. 2016; Joung & Sander 2013). The core 
technologies now most commonly used include: homing endonucleases or meganucleases, zinc-finger nucleases 
(ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short 
palindromic repeats (CRISPR)-CRISPR-associated protein 9 (CRISPR-Cas9). This process is most often used to 
achieve gene knockout via insertions and/or deletions. 
Targeted genome editing relies on the use of engineered nucleases, that are linked to a customizable 
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sequence-specific DNA-binding domain which is fused to a nuclease that cleaves DNA to induce double-strand 
breaks (DSB s) at specific sites, which are then repaired by mechanisms that can be exploited to create sequence 
alterations (Joung & Sander 2013). The Common feature of all Nuclease-mediated genome editing is the 
generation of DNA double-strand breaks (DSBs). The result of DSBs is the activation of cellular DNA repair 
pathways, which facilitate the introduction of site-specific genomic modifications (Gaj et al. 2016).  The DSBs 
are then repaired either by non-homologous end joining (NHEJ) or homologous recombination (HR). Non-
homologous end-joining of DNA at the double stranded break is a highly error prone pathway that often leads to 
the generation of random base insertions or deletions of nucleotides leading to a shift in the reading frame, which 
is expected to have a major disruptive effect on the structure and thus the function of the protein translated from 
this mutant gene upon re-joining (Gerlai 2016). Homologous recombination is an error-free mechanism for DSB 
repair. It uses a homologous DNA sequence as template.  
Nuclease-mediated genome editing enables genetic studies that were previously difficult or impossible 
to perform (Joung & Sander 2013). The resultant loss-of-function mutations could be used to create somatic cell-
based models of disease. Alternatively, precise insertions can be introduced into endogenous genes (Joung & 
Sander 2013). 
One major concern associated with all targeted nucleases is the observation of off-target mutations (Gaj 
et al. 2016). These can be reduced with improving the specificity of the tools for the target sequences. Targeted 
nucleases have been used in a technique known as gene drive to confer particular phenotypes in hosts, which are 
inherited by their progeny (Gaj et al. 2016). Gene drives have been applied in the population control of malaria 
mosquitos Anopheles stephensi (Gantz et al. 2015) and Anopheles gambiae (Hammond et al. 2016). Concerns 
have arisen about the potential societal and environmental impact of this technology (Esvelt et al. 2014; Akbari 
et al. 2015), owing to the ease with which CRISPR-Cas9 can be programmed (Gantz & Bier 2015). Debate has 
ignited on finding avenues to minimize the risk of gene-edited organisms escaping from the laboratory (DiCarlo 
et al. 2015). 
4.4.2.2.1 Meganucleases for targeted genome engineering 
Meganucleases, also termed homing endonucleases, are rare-cutting highly specific DNA cleaving enzymes that 
are encoded within the genome of nearly all forms of microbial life as well as in eukaryotic mitochondria and 
chloroplasts (Stoddard 2014). They are highly specific endonucleases which recognize and cleave the exon-exon 
junction sequence wherein their intron resides, thus giving rise to the moniker “homing endonuclease” (Silva et 
al. 2011). These enzymes recognize and cleave long DNA sequences (typically 18–30 base pairs) generating 
double-strand DNA breaks (DSBs) (Stoddard 2011). The binding and cleavage domains in homing 
endonucleases are not modular. This overlap in form and function make their repurposing challenging, and limits 
their utility for more routine applications of genome editing (Gaj et al. 2016).   
4.4.2.2.2 Targeted gene knockout by zinc finger nucleases 
Zinc-finger nucleases (ZFNs) are artificial restriction enzymes which function as a heterodimer in which each 
subunit consists of two functional domains, which are generated by fusing a zinc finger (DNA-binding domain) 
to a nuclease (DNA-cleaving domain comprised of a Fok I restriction endonuclease) (Urnov et al. 2010). 
Dimerization of the ZFN proteins is mediated by the FokI cleavage domain. When the DNA-binding and DNA-
cleaving domains are fused together, a highly specific pair of ‘genomic scissors’ is created. The FokI domains 
must dimerize for activity, thus increasing target specificity by ensuring that two proximal DNA-binding events 
must occur to achieve a double-stranded break. The resulting cleavage event is what enables genome editing to 
happen. After a break is created, the cell seeks to repair it (Carroll et al. 2011). Zinc finger domains can be 
engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique 
sequences within complex genomes. Each ZFN is composed of three or four zinc-finger domains, with each 
individual domain made of 30 amino acid residues. Each individual zinc fingers domain typically recognizes and 
interacts with DNA triplets (Gaj et al. 2016). The difficulty associated with constructing zinc-finger arrays that 
can effectively recognize all DNA triplets has hindered their widespread adoption of the ZFN technology (Gaj et 
al. 2016). 
4.4.2.2.3 Genome editing with Transcription activator-like effector nucleases (TALENs) 
Transcription Activator-Like Effector (TALE) proteins are bacterial effectors. A TALE binding domain consists 
of a tandem array of repeated segments each consisting of 34 amino acids (Gerlai 2016). The amino acid 
sequence of these repeats is mostly the same EXCEPT for the amino acids at positions 12 and 13. Each repeat 
contacts DNA via the amino acid residues at positions 12 and 13, known as the repeat variable di-residues (Gaj 
et al. 2016). The specificity of each individual TALE repeat is determined by the identities of two hypervariable 
residues (Joung & Sander 2013). Each of these variable pair of amino acids in a TALE binds to a specific 
nucleotide in DNA (Gaj et al. 2016). TALE genes can be mutated to generate sequence-specific DNA binding 
proteins. TALEs are typically assembled to recognize between 12- to 20-bps of DNA, with more bases typically 
leading to higher genome-editing specificity. TALEs can be fused to nucleases to form Transcription Activator-
Like Effector Nucleases (TALENs) for targeted double-stranded breaks in DNA. TALENs are similar in design 
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to ZFNs having a non-specific FokI nuclease domain linked to a customizable DNA-binding domain (Joung & 
Sander 2013). Like ZFNs, dimerization of TALEN proteins is mediated by the FokI cleavage domain, which cuts 
within a 12- to 19-bp spacer sequence that separates each TALE binding site (Gaj et al. 2016). TALENs are 
artificial restriction enzymes able to cut DNA only where they encounter a specific sequence of nucleotides. This 
can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR). TALENs are easier 
to design and researchers can create specific tools by using simple protein-DNA codes (Joung & Sander 2013). 
4.4.2.2.4 CRISPR/Cas9-Based Genome Editing 
The Clustered, Regularly Interspaced, Short Palindromic Repeat (CRISPR) system is a form of adaptive 
immunity found in bacteria (Marraffini 2016), which acts against DNA from invading viruses and plasmids 
using RNA-guided DNA cleavage by Cas proteins (Gaj et al. 2016).  In nature, the Cas9 endonuclease forms a 
complex with two RNA molecules, CRISPR RNA (crRNA) and transactivating crRNA (tracrRNA), which guide 
the CRISPR-associated endonuclease (Cas9) to recognize and cleave a site (Marraffini 2016). 
CRISPR/ Cas9 system used in biotechnology consists of two components: a “guide” RNA (gRNA) and 
a non-specific CRISPR-associated endonuclease (Cas9). The guide RNA, is a short synthetic chimeric molecule, 
composed of essentials functional portions of crRNA and tracrRNA which are required for Cas9-binding and a 
user-defined 20 nucleotide “spacer” or “targeting” sequence that is complementary to the genomic target to be 
modified (Doudna &  Charpentier 2014). Thus, one can change the genomic target of Cas9 by simply changing 
the targeting sequence present in the gRNA.  
The Cas9 target sequence consists of a 20-bp DNA sequence complementary to the gRNA and the 
trinucleotide (5′-NGG-3′) protospacer adjacent motif (PAM) recognized by Cas9 (Doudna & Charpentier 2014). 
The end result is a double stranded break induced by Cas9, which is resolved either by non-homologous end 
joining (NHEJ) or homologous recombination (HR). The advantage of the CRISPR system over the TALEN 
method is that it is comparably simpler to perform because target site recognition is mediated entirely by the 
gRNA (Gaj et al. 2016). CRISPR-Cas9 has emerged as the most flexible and user-friendly platform for genome 
editing by eliminating the need for engineering new proteins to recognize each new target site, and thus its use is 
rapidly spreading across molecular biology laboratories (Gerlai 2016). 
 
5. CONCLUSION 
This review was written in an attempt to present the reader with a decent spectrum of the available methods for 
gene function analysis that have been applied in the past decade. Genetic engineering provides powerful tools for 
the study of gene function in both cells and organisms. This review has revealed several methods for the 
functional analysis of genes. Ultimately the choice of method to be applied will rely on several factors such as; 
the research budget, the expected throughput, the size of genome to be analysed, the application sought, the 
objectives to be met and the acceptable safety levels demanded among other reasons. A simple database 
searching for homology could predict a gene's function, reporter genes can demonstrate when and where a gene 
is expressed, microarrays can monitor the expression of thousands of known genes at once, targeted mutations 
can reveal gene function, cells and animals containing mutated genes can be made and gene targeting makes it 
possible to produce transgenic animals. 
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